According to the World Cancer Report, cancer rates will continue to rise to 15 million new cases by 2020. Global biopsy device market will be USD 2.8 Billion by 2025.
Big Market Research has announced a new Report Package "Global Blood Screening Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/blood-screening-global-research-2015-2019-market Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/337179
Global Blood Screening market size was USD 3.61 Billion in 2022 and it is forecasted to reach USD 5.14 Billion by 2030. Blood Screening Industry's Compound Annual Growth Rate will be 8.5% from 2023 to 2030.
The global cell-free fetal DNA testing market is forecast to expand at a CAGR of 10% and thereby increase from a value of US$1.5 Bn in 2023, to US$2.9 Bn by the end of 2030.
Global blood screening market is expected to reach a healthy CAGR of 9.7% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Blood Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blood Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The global blood pressure monitoring devices market is expected to reach a market size of USD 3.18 Billion by 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Rapid advancements in healthcare technology, increasing prevalence of heart diseases and hypertension, driven by a growing geriatric population and associated health conditions, and increasing prevalence of lifestyle diseases are among some of the major factors propelling growth of the global blood pressure monitoring devices market.
Research Beam added a report “Global Blood Screening Market 2015 to 2019”. About blood screening, Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception. Enquiry @ http://www.researchbeam.com/blood-screening-global-research-2015-2019-market/enquire-about-report
A number of tests are generally recommended during pregnancy to be able to identify any potential prenatal abnormalities. With advent of technology enabling this, demand for blood screening procedures and products will also be on the rise. Growing significance of molecular biology techniques like next generation sequencing (NGS), western blot assay, and enzyme linked immunosorbent assay (ELISA) further point to a host of opportunities emerging for blood screening market players.
Global blood screening market is expected to reach a healthy CAGR of 9.7% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Blood Screening Market: By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), By Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) — Global Forecast till 2023
Blood screening is a medical process in which donated blood is mainly tested for HIV1, HIV2, HBV, HCV, malaria, syphilis, and various other infectious diseases. Donated blood is screened for these infectious diseases to reduce the risk of transfusion-transmitted infections (TTIs).
The new Blood Screening Market report offers a comprehensive study of the present scenario of the market coupled with major market dynamic. Also, it highlights the in-depth market analysis with the latest trends, drivers and its segments with respect to regional and country. Further, this report profiles top key players of the blood screening and analyze their market share, strategic development and other development across the globe.
This new 225-page report from Venture Planning Group presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products. The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Complete report is spread across 225 pages is available @ http://www.reportsnreports.com/reports/274140-2014-assessments-of-blood-typing-grouping-and-screening-market-strategic-profiles-of-leading-suppliers.html.
Big Market Research present “Global Blood Screening Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-blood-screening-industry-2015-research-report-market 2015 Global Blood Screening Industry Report, is a professional and comprehensive market study with valuable inputs from industry experts. The report offers industry overview including basic aspects such as market segmentation, main applications analysis, chain structure overview, market development prospects along with detailed market forecast.
The report "Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021"The global blood screening market is expected to reach USD 2.80 Billion by 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7% from 2016 to 2021
This report focuses on the global Blood Screening and Typing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Blood Screening and Typing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
he Prenatal Testing & Newborn Screening Market deals with the development of medical technology specifically relating to the pregnancy & baby care. Prenatal screening has become a standard part of pregnancy medical care for being aware of fetal defects. Newborn screening is a screen test to newborn babies to know whether they have any disorders or not.
Global Blood Screening Market, By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Global maternal blood test market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing demand for non- invasive prenatal testing and rising risk of chromosomal abnormalities in babies are the factor for the growth of this market.
The occurrences of new types of pathogens, increasing investment rates for advanced technology creation, growing geriatric population, and government’s favourable blood screening policies are likely to boost the growth of the blood screening market in the 2020-2027 forecast period.
Blood Screening Market: By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), By Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) — Global Forecast till 2023
Blood Screening is a medical procedure where the donated blood is tested for the presence or absence of HIV, HBV, HCV, malaria, syphilis, and for various other infectious diseases. The donated blood is screened for these infectious diseases to lessen the risk of transfusion-transmitted infections (TTIs).
It is expected that the growing neonatal population base, the cases of congenital diseases in newborns, favorable government initiatives & regulations, and technical developments will act as critical drivers of the demand for newborn screening.
The global cellular health screening market is growing at a CAGR of 9.32% and is expected to reach $xx million, during the forecast period 2023-2032. Read More
The global vacuum blood collection tube market is expected to grow with a CAGR of 7.15% during the forecast years, 2024-2032. Get more insights into our blog
Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments & Kits and Reagents), Application (Disease Screening and Blood Grouping), and End User (Hospitals, Diagnostic Laboratories, and Plasma Fractionation Companies)
Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test Type (Blood Marker tests, Imaging Test, Genetic Test, Immunohistochemistry Test); End User (Hospitals, Diagnostic Centers, Cancer Institutes, Research Laboratories), and Geography
The escalating prevalence of various cancers, such as leukemia and lymphoma, owing to the stressful lives, longer working hours, and excessive smoking and alcohol consumption is among the primary factors driving the cord blood banking services market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cord-blood-banking-services-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
According to the latest research report by IMARC Group, The United States newborn screening market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-newborn-screening-market
According to our latest study on “Blood Filter Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Material, Application, and End User,” the market is projected to reach US$ 535.634 million by 2028 from US$ 405.226 million in 2021; it is estimated to grow at a CAGR of 4.1% from 2021 to 2028. The report highlights the key factors governing the market growth and prominent players with their developments in the market. The growth of the blood filter market is primarily attributed to a rapid increase in the burden of chronic diseases, a surge in cases of trauma and accidents, and a rising number of blood transfusion procedures across the world. However, product recalls restraining the market growth.
According to the latest research report by IMARC Group, The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. More Info:- https://www.imarcgroup.com/drug-screening-market
The global cellular health screening market is growing at a CAGR of 9.32% and is expected to reach $xx million, during the forecast period 2023-2032. Read More https://inkwoodresearch.com/reports/cellular-health-screening-market/
The blood filter market is projected to reach US$ 535.634 million by 2028 from US$ 405.226 million in 2021; it is estimated to grow at a CAGR of 4.1% from 2021 to 2028.
Sales and market share estimates for leading suppliers of blood typing, grouping and infectious disease screening tests by country and individual product.
Global blood transfusion diagnostics market size is expected to reach $6.04 Bn by 2028 at a rate of 8.1%, segmented as by type, instruments and kits, reagents, other types
Maternal blood test refers to a type of prenatal screening test and provide an assessment of the likelihood of a pregnancy being impacted by a chromosome disorder or certain behavioral issues https://www.databridgemarketresearch.com/reports/global-maternal-blood-test-market
This report provides a worldwide overview of the blood banking market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. Read The Complete Report On : http://www.bigmarketresearch.com/2015-global-blood-banking-facilities-test-volumes-and-sales-forecasts-for-typing-grouping-and-infectious-disease-screening-tests-by-country-market
The Global HIV Diagnosis Market is projected to grow from USD 3.12 billion in 2020 to USD 5.28 billion by 2026 at a CAGR of over 9.2% during the forecast period.
Latest research report “Blood Transfusion Diagnostics Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2kCXBjc Request a Sample: http://bit.ly/2lNowsB
The Report on “Blood Typing, Grouping and NAT Screening Tests Industry Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2016-emerging-blood-typing-grouping-and-nat-screening-tests-and-strategic-profiles-of-leading-reagent-and-instrument-suppliers-market/enquire-about-report
In the developed markets such as the USA, the UK, Australia and others, drug tests are considered much more reliable and accurate than simple drug screens, although these tests are lot pricier i.e. ~ $200 and take a lot longer to perform i.e. around 1-7 days. However, these tests are far more in demand for pre-employment services, rehabilitation services, sports & training academy, defence departments and others.
Visit Here: https://www.grandresearchstore.com/life-sciences/newborn-screening-devices-market-24 In this report, the global Newborn Screening Devices market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Major players in the blood transfusion diagnostics market are BAG Health Care GmbH, Grifols, Bio-Rad Laboratories, Inc., Abbott Laboratories and Immucor Inc. Read More @ https://bit.ly/2R3FOBv
Major players in the blood group typing market are Grifols, Bio-Rad Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Quotient....@ @ https://bit.ly/3GAfqV0